Related Experiment Video
Updated: Jul 15, 2026
05:56
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Newborn screening for cystic fibrosis
1Division of Pediatric Pulmonology, University of Wisconsin Hospital and Clinics, 600 Highland Avenue, Room K4/946, Madison, WI 53792, USA. mjrock@wisc.edu
Clinics in Chest Medicine
|May 1, 2007
Summary
Newborn screening for cystic fibrosis (CF) is now possible due to advancements in immunoreactive trypsinogen and DNA analysis. Early detection improves nutrition, cognitive function, lung health, and survival rates in infants.
Area of Science:
- Medical screening
- Pediatrics
- Genetic disorders
Background:
- Cystic Fibrosis (CF) screening was considered in the 1970s but lacked adequate technology.
- Technological advancements have enabled accurate neonatal screening for CF.
Purpose of the Study:
- To evaluate the feasibility and benefits of newborn screening for Cystic Fibrosis.
- To highlight the impact of early CF detection on infant health outcomes.
Main Methods:
- Utilized immunoreactive trypsinogen analysis.
- Employed DNA mutation analysis, often in conjunction with trypsinogen testing.
Main Results:
- Newborn screening for CF is now technologically feasible.
- Studies show benefits in nutrition, cognitive development, and pulmonary function.
- Improved survival rates have been observed in screened infants.
Conclusions:
- Newborn screening for Cystic Fibrosis is a valuable tool for early intervention.
- Early detection through screening significantly enhances long-term health and survival.
- Continued development and implementation of CF newborn screening programs are recommended.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...